Egg Allergy Drug Pipeline Research 2024 Featuring Aimmune Therapeutics, DBV Technologies, and ASIT Biotech
April 12, 2024 09:59 ET
|
Research and Markets
Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Egg allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive insights...
Peanut Allergy Drug Landscape Analysis Report 2024: Comprehensive Insights of 12+ Companies and 15+ Pipeline Drugs
April 11, 2024 09:11 ET
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Peanut Allergy - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Peanut Allergy - Pipeline Insight,...
Allergy Immunotherapy Soars: Anticipating a $2.69 Billion Market by 2028 with an Impressive CAGR of 8.12%
February 05, 2024 04:41 ET
|
Research and Markets
Dublin, Feb. 05, 2024 (GLOBE NEWSWIRE) -- The "Global Allergy Immunotherapy Market (2023-2028) by Type, Application and Distribution Channel, and Geography, Competitive Analysis, Impact of Covid-19,...
Allergy Immunotherapy Market Size to Exceed USD 5.6 billion by 2031, with a Robust CAGR of 9.6%| States Transparency Market Research, Inc.
January 11, 2024 11:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Jan. 11, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global allergy immunotherapy market is estimated to flourish at a CAGR of 9.6% from...
Allergy Immunotherapy Market Size to Surpass USD 3.20 Billion in 2030, exhibiting a CAGR of 9.5%
June 19, 2023 08:00 ET
|
Fortune Business Insights
Pune, India, June 19, 2023 (GLOBE NEWSWIRE) -- The global allergy immunotherapy market size was valued at USD 1.58 billion in 2022. The market is anticipated to grow from USD 1.70 billion in 2023 to...
Sami Nallamshetty, MD, FACAAI Uses Immunotherapy as a Powerful Tool to Treat Asthma and Allergies
May 19, 2023 12:37 ET
|
Florida Medical Clinic
TAMPA. Fla., May 19, 2023 (GLOBE NEWSWIRE) -- “People might know that immunotherapy can fight allergies, but it can help asthma sufferers too,” says Dr. Nallamshetty, who specializes in pediatric...
HpVac reports positive effects of its lead compound HpVac-R13 in a murine model of allergic asthma following oral administration
March 27, 2023 04:00 ET
|
AKAMPION
- Study results indicate beneficial effects on airway hyperresponsiveness, remodeling and inflammation Geneva, Switzerland, March 27, 2023 – HpVac SA, a company developing novel preventive and...
HpVac Appoints Joana Vitte, MD, PhD, as Chief Scientific Officer
November 23, 2022 04:00 ET
|
AKAMPION
- Significant expansion of allergy research expertise Geneva, Switzerland, November 23, 2022 – HpVac SA, a company developing novel preventive and therapeutic first-line therapies against...
Global Allergy Immunotherapy Market Size to grow USD 4.5 Billion by 2030 | CAGR of 9.5%; Spherical Insights & Consulting
October 24, 2022 05:00 ET
|
SPHERICAL INSIGHTS LLP
New York, United States, Oct. 24, 2022 (GLOBE NEWSWIRE) -- According to a research report published by Spherical Insights & Consulting, the Global Allergy Immunotherapy Market Size to grow from...
HpVac Announces New Animal Data of its Lead Compound Demonstrating Protection Against Allergic Asthma
October 18, 2022 04:00 ET
|
AKAMPION
- Major milestone for accelerating the development of HpVac-13 in allergic diseases Geneva, Switzerland, October 18, 2022 – HpVac SA, a company developing novel preventive and therapeutic...